Personalized Therapy for Multiple Myeloma

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Hematology, Oncology
Cover of the book Personalized Therapy for Multiple Myeloma by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319618722
Publisher: Springer International Publishing Publication: October 30, 2017
Imprint: Springer Language: English
Author:
ISBN: 9783319618722
Publisher: Springer International Publishing
Publication: October 30, 2017
Imprint: Springer
Language: English

This book provides the clinician with concise, practical guidance on risk stratification and therapeutic decision making in patients with multiple myeloma.  In addition, the available clinical trial and research data are summarized into meaningful reviews and evidence-based recommendations for treatment are presented. The coverage encompasses all phases and forms of disease, including high-risk myeloma.

Over recent decades, greater understanding of the biology of myeloma has fostered the development of new, more effective drugs, leading to remarkable improvements in survival. To continue this momentum, several recent prospective trials have aimed to identify further potential therapeutic targets or to evaluate various combinations of anti-myeloma agents. The increasing abundance of management options makes the decision making complex in different phases of the disease. This book will offer the clinician valuable assistance in the choice and sequencing of therapies, highlighting the need for a personalized approach that reflects the growing recognition that myeloma is not one uniform disease.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This book provides the clinician with concise, practical guidance on risk stratification and therapeutic decision making in patients with multiple myeloma.  In addition, the available clinical trial and research data are summarized into meaningful reviews and evidence-based recommendations for treatment are presented. The coverage encompasses all phases and forms of disease, including high-risk myeloma.

Over recent decades, greater understanding of the biology of myeloma has fostered the development of new, more effective drugs, leading to remarkable improvements in survival. To continue this momentum, several recent prospective trials have aimed to identify further potential therapeutic targets or to evaluate various combinations of anti-myeloma agents. The increasing abundance of management options makes the decision making complex in different phases of the disease. This book will offer the clinician valuable assistance in the choice and sequencing of therapies, highlighting the need for a personalized approach that reflects the growing recognition that myeloma is not one uniform disease.

More books from Springer International Publishing

Cover of the book The Fundamentals of Human Factors Design for Volunteered Geographic Information by
Cover of the book Patch-Based Techniques in Medical Imaging by
Cover of the book New Trends in E-service and Smart Computing by
Cover of the book Regional Research Frontiers - Vol. 1 by
Cover of the book Handbook of Bioenergy by
Cover of the book Biomarkers for Endometriosis by
Cover of the book The Meaning of Form in Contemporary Innovative Poetry by
Cover of the book On the Nature of Effective CIO/CEO Communication by
Cover of the book Enhancing Cleanup of Environmental Pollutants by
Cover of the book Stochastic Integration in Banach Spaces by
Cover of the book Recent Advances in Information Systems and Technologies by
Cover of the book Practical Aspects of Declarative Languages by
Cover of the book Penalty, Shrinkage and Pretest Strategies by
Cover of the book Scala Design Patterns by
Cover of the book Europe and Iran’s Nuclear Crisis by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy